AVNS & Siemens Healthineers Team Up on Advanced Integrated Pain Care
Avanos Medical teams up with an imaging partner to pair RFA with mobile imaging, targeting the shift of complex pain procedures to outpatient care.
Avanos Medical, Inc. (AVNS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Avanos Medical, Inc. (AVNS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Why Is Avanos Medical (AVNS) Down 0.5% Since Last Earnings Report?
Avanos Medical (AVNS) reported earnings 30 days ago. What's next for the stock?
Avanos Medical Gains on Q3 Earnings Beat, Raises '25 Sales View
Avanos Medical posts a Q3 earnings and sales beat, boosts 2025 outlook as Specialty Nutrition drives solid double-digit growth.
Avanos Medical, Inc. (AVNS) Q3 2025 Earnings Call Transcript
Avanos Medical, Inc. ( AVNS ) Q3 2025 Earnings Call November 5, 2025 9:00 AM EST Company Participants Jason Pickett - Vice President of Tax & Treasurer David Pacitti - CEO & Director Scott Galovan - CFO & Senior VP Conference Call Participants Daniel Stauder - Citizens JMP Securities, LLC, Research Division Presentation Operator Good morning, ladies and gentlemen, and welcome to the Avanos Third Quarter 2025 Earnings Conference Call. [Operator Instructions] This call is being recorded on Wednesday, November 5, 2025.
Avanos Medical (AVNS) Q3 Earnings and Revenues Beat Estimates
Avanos Medical (AVNS) came out with quarterly earnings of $0.22 per share, beating the Zacks Consensus Estimate of $0.16 per share. This compares to earnings of $0.36 per share a year ago.
Avanos Medical: After Transformation Efforts, I Expect Inorganic Growth To Push The Price Up
Avanos Medical is deeply undervalued, with strong international expansion, aggressive M&A strategy, and a new CFO poised to drive inorganic growth. AVNS operates in high-growth markets, maintains a solid balance sheet with low debt, and trades at a significant discount to sector peers on earnings and book value. Ongoing transformation, divestitures, and stock repurchases are expected to enhance operating and free cash flow margins, further boosting investor appeal.
Avanos Medical Stock Down as Q2 Earnings Miss Estimates, Margins Down
AVNS shares dip 12% as Q2 earnings miss estimates, margins shrink, and tariff pressures weigh on profitability.
Avanos Medical, Inc. (AVNS) Q2 2025 Earnings Call Transcript
Avanos Medical, Inc. (NYSE:AVNS ) Q2 2025 Earnings Conference Call August 5, 2025 9:00 AM ET Company Participants David C. Pacitti - Chief Executive Officer Jason M.
Avanos Medical (AVNS) Misses Q2 Earnings Estimates
Avanos Medical (AVNS) came out with quarterly earnings of $0.17 per share, missing the Zacks Consensus Estimate of $0.18 per share. This compares to earnings of $0.34 per share a year ago.
New Strong Sell Stocks for July 15th
DDD, AVNS and BABA have been added to the Zacks Rank #5 (Strong Sell) List on July 15, 2025.
Avanos Medical (AVNS) International Revenue in Focus: Trends and Expectations
Explore Avanos Medical's (AVNS) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.
